INMUNE BIO INC. Increase (Decrease) in Deferred Liabilities
INMUNE BIO INC. (INMB) reported Increase (Decrease) in Deferred Liabilities of -$517.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2026-08-06
- INMUNE BIO INC. increase (decrease) in deferred liabilities for the quarter ending 2025-12-31 was $0.00.
- INMUNE BIO INC. increase (decrease) in deferred liabilities for the quarter ending 2025-09-30 was -$511.00K, a 1925.00% decline year-over-year.
- INMUNE BIO INC. increase (decrease) in deferred liabilities for the quarter ending 2025-06-30 was $31.00K, a 3000.00% increase year-over-year.
- INMUNE BIO INC. increase (decrease) in deferred liabilities for the quarter ending 2025-03-31 was -$37.00K, a 219.35% decline year-over-year.
- INMUNE BIO INC. increase (decrease) in deferred liabilities for fiscal 2025 was -$517.00K, a 1946.43% decline from fiscal 2024.
- INMUNE BIO INC. increase (decrease) in deferred liabilities for fiscal 2024 was $28.00K.
- INMUNE BIO INC. increase (decrease) in deferred liabilities for fiscal 2023 was -$127.00K, a 189.44% decline from fiscal 2022.
- INMUNE BIO INC. increase (decrease) in deferred liabilities for fiscal 2022 was $142.00K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$511.00K derived: sum of 2 quarters · filed 2026-03-30 | -$480.00K derived: sum of 3 quarters · filed 2026-08-06 | -$517.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$511.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$480.00K derived: sum of 2 quarters · filed 2026-08-06 | -$517.00K 10-Q · filed 2025-10-30 | -$549.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$6.00K 10-Q · filed 2026-08-06 | -$38.00K derived: sum of 3 quarters · filed 2026-08-06 | -$10.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$37.00K 10-Q · filed 2026-05-07 | -$69.00K derived: sum of 2 quarters · filed 2026-05-07 | -$41.00K derived: sum of 3 quarters · filed 2026-05-07 | -$40.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$4.00K derived: sum of 2 quarters · filed 2026-03-30 | -$3.00K derived: sum of 3 quarters · filed 2026-03-30 | $28.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $29.00K derived: sum of 2 quarters · filed 2025-10-30 | $60.00K 10-Q · filed 2025-10-30 | $53.00K derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $32.00K 10-Q · filed 2025-08-07 | $25.00K derived: sum of 3 quarters · filed 2025-08-07 | -$39.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $31.00K 10-Q · filed 2025-05-08 | $24.00K derived: sum of 2 quarters · filed 2025-05-08 | -$40.00K derived: sum of 3 quarters · filed 2025-05-08 | -$71.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$71.00K derived: sum of 2 quarters · filed 2025-03-27 | -$102.00K derived: sum of 3 quarters · filed 2025-03-27 | -$127.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$95.00K derived: sum of 2 quarters · filed 2024-10-31 | -$120.00K 10-Q · filed 2024-10-31 | -$282.00K derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | -$31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$56.00K 10-Q · filed 2024-08-01 | -$218.00K derived: sum of 3 quarters · filed 2024-08-01 | $84.00K derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | -$25.00K 10-Q · filed 2024-05-09 | -$187.00K derived: sum of 2 quarters · filed 2024-05-09 | $115.00K derived: sum of 3 quarters · filed 2024-05-09 | |
| 2022-12-31 | -$162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $140.00K derived: sum of 2 quarters · filed 2024-03-28 | $142.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $302.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $304.00K 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | $2.00K 10-Q · filed 2023-08-07 | |||
| 2020-12-31 | $66.83K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $177.70K derived: sum of 2 quarters · filed 2021-03-04 | $177.70K 10-K · filed 2021-03-04 | |
| 2020-09-30 | $110.88K 10-Q · filed 2020-11-05 | $110.88K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |